v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-X-L

被引:23
作者
Chen, Q
Turner, J
Watson, AJM
Dive, C
机构
[1] UNIV MANCHESTER, SCH BIOL SCI, MOL PHARMACOL GRP, MANCHESTER M13 9PT, LANCS, ENGLAND
[2] UNIV MANCHESTER, DEPT MED, MANCHESTER M13 9PT, LANCS, ENGLAND
基金
英国医学研究理事会;
关键词
apoptosis; v-Abl tyrosine kinase; Bcl-X-L survival signals;
D O I
10.1038/sj.onc.1201371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrated previously that the activation of v-Abl protein tyrosine kinase (PTK) in IC.DP murine pre-mast cells resulted in suppression of apoptosis after withdrawal of interleukin 3 (IL-3), that protein kinase C (PKC) translocated to the nucleus 6 h after v-Abl PTK activation and that inhibition of PKC restored apoptosis after IL-3 deprivation in the presence of v-Abl PTK activity. Here we demonstrate that v-Abl PTK activation is followed by an approximately twofold increase in mRNA level of Bcl-X-L by 6 h and a corresponding increase in Bcl-X-L protein level by 24 h. Bcl-x(L) RNA and protein decreased in IL-3 deprived cells in the absence of v-Abl PTK activity. Exposure of cells with v-Abl PTK active to the PKC inhbitor calphostin C (125 ng/ml) prevented the increase in Bcl-x(L) protein and resulted in apoptosis. No changes in Bax or Bcl-2 protein level were noted after IL-3 withdrawal and/or activation of v-Abl PTK. Bak was barely detectable and Bad protein level decreased in cells undergoing apoptosis. The data suggest that suppression of apoptosis by v-Abl PTK in the absence of IL-3 is associated with PKC signalling and the upregulation of Bcl-x(L) in IC.DP cells.
引用
收藏
页码:2249 / 2254
页数:6
相关论文
共 43 条
[1]   BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS [J].
BEDI, A ;
BARBER, JP ;
BEDI, GC ;
ELDEIRY, WS ;
SIDRANSKY, D ;
VALA, MS ;
AKHTAR, AJ ;
HILTON, J ;
JONES, RJ .
BLOOD, 1995, 86 (03) :1148-1158
[2]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[3]  
BOYD JM, 1995, ONCOGENE, V11, P1921
[4]  
CARROLL MP, 1990, J BIOL CHEM, V265, P19812
[5]  
CHAPMAN RS, 1994, CANCER RES, V54, P5131
[6]  
CHAPMAN RS, 1995, MOL PHARMACOL, V48, P334
[7]  
CHEN CY, 1995, ONCOGENE, V11, P1487
[8]  
Chen Q, 1997, J CELL SCI, V110, P379
[9]  
CHUNG SW, 1995, ONCOGENE, V10, P1261
[10]  
CORTEZ D, 1995, MOL CELL BIOL, V15, P5531